We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Telo Genomics Corp (TELO) NPV

Sell:0.33 CAD Buy:0.36 CAD Change: 0.005 CAD (1.39%)
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
Sell:0.33 CAD
Buy:0.36 CAD
Change: 0.005 CAD (1.39%)
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
Sell:0.33 CAD
Buy:0.36 CAD
Change: 0.005 CAD (1.39%)
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Telo Genomics Corp. is a Canada-based biotech company. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for numerous diseases that display genomic instability. Its lead application, Telo-MM is being developed to provide information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. The Company's TeloView software consists of two parts, analytical software and a corresponding report designed for clinical decision making. TeloView utilizes the three-dimensional analysis of approximately six parameters generated from the telomeres of a single cell. Its TeloView software generates a report for the clinician that contains information, including the stage of a given disease, its rate of progression and how it responds to therapy. Its solutions include liquid biopsies and related technologies in oncology and neurological diseases.

Contact details

Mars Centre, 101 College St Suite 200
M5G 1L7
+1 (416) 6738487

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
21.24 million CAD
Shares in issue:
59.42 million
Canadian Venture Exchange
Canadian dollars

Key personnel

  • Guido Baechler
    Chairman of the Board
  • Sherif Louis
    President, Chief Executive Officer
  • Christopher Ross
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.